The advancements in molecular research and continued untiring efforts of the research industry to develop better more precisely applicable Pharmaceuticals as well as agro compounds would have not been possible without the advent of Chiral technologies and their applications.
The usage of chiral molecules is at the very centre of this technological revolution when coupled with the application of chiral technologies as: Chiral Pool, Resolution, Biocatalysts, or asymmetric analysis creates the required compounds. The majority of development activity is routed through fine chemical companies which are additionally trying to upgrade their capabilities in order to provide to the entire portfolio of pharmaceutical drugs for application in the consumer arena.
Such ramping up of operations by companies in order to develop and upgrade basic molecules for wide ranging applications is also bringing the focus of chiral technologies into the development of clinical cures.
This report - Looking at Chiral Technologies - introduces the concept of Chiral Technologies supplementing it with its variants and explaining the actions undertaken by the industry towards developing such compounds jointly and deriving common benefits of clinical nature. The report also analyzes the global market growth forecasts driven by two very important components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals which are synthesized in bulk nature which are contributing to deriving drug streams worldwide.
The report explains the sales of Single Enantiomer pharma on a YOY basis, which is being controlled by certain regulatory constraints. The report also presents an insight on the synergies developed by the industr y majors by building long term partnerships as well as sustaining healthy competition which will lead to the development of the industry as a whole.
The market for Chiral Technologies has been demarcated by end user applications in this report further to which the report provides a future perspective on the industry outlook for Chiral Technologies.
A. Executive Summary
B. Understanding the Chiral Concept
C. Industry Profile
D. Different Chiral Models for Flexible Markets
E. Intellectual Property Issues
F. Bringing the Molecule to a Commercial Scale - Issues & Challenges
G. How the Pharma Industry is Driving Chiral Technologies
H. Market Demarcations by Chiral Applications
I. Chiral Technology Industry - Future Perspective
J. Major Market Players
L. Glossary of Terms
- Altus Biologics Inc
- Ascot Fine Chemicals
- Callery Chemical Company
- Cambrex Corporation
- Catalytica Inc
- Chemi SpA
- ChromTech International
- Daicel Chemical Industries Ltd
- Daiso Company Ltd
- Great Lakes Fine Chemicals
- IMI (TAMI)
- Johnson Matthey plc
- Kaneka Corporation
- Lonza Ltd
- Oxford Asymmetry International
- Pfanstiehl Laboratories
- Sepracor Inc
- Synthon Chiragenics Corporation
For more information visit http://www.researchandmarkets.com/reports/c60415
Research and Markets
Fax: +353 1 4100 980